Beta blockers beneficial in COPD

In this large observational cohort of >2,000 patients with COPD, the adjusted risk of mortality and COPD exacerbations were both lower in those on beta blockers (both hazard ratios were 0.7, CI 0.6-0.8). These data suggest there is no reason to avoid beta blockers in patients with COPD, and beta blockers may actually be associated with a lower risk of death and COPD exacerbations (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment